49 results on '"Goto, Koichi"'
Search Results
2. Intracranial outcomes of 1L selpercatinib in advanced RET fusion-positive NSCLC: LIBRETTO-431 study.
3. Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer
4. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is ‘cured’ from postoperative recurrence?
5. Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations
6. Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
7. Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer
8. Docetaxel for platinum-refractory advanced thymic carcinoma
9. Genomic profiling of small-cell lung cancer: the era of targeted therapies
10. Personality traits and coping styles explain anxiety in lung cancer patients to a greater extent than other factors
11. Randomized controlled trial comparing docetaxel–cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†
12. Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer
13. Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis
14. Low-dose Irinotecan as a Second-line Chemotherapy for Recurrent Small Cell Lung Cancer
15. Protective Effect of Magnesium Preloading on Cisplatin-induced Nephrotoxicity: A Retrospective Study
16. Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: Identification of prognostic microenvironmental factors after chemoradiation
17. RET fusion gene: Translation to personalized lung cancer therapy
18. Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo
19. Renal Toxicity Caused by Brand-name Versus Generic Cisplatin: A Comparative Analysis
20. Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung
21. Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer
22. Long-Term Outcomes of 50 Cases of Limited-Resection Trial for Pulmonary Ground-Glass Opacity Nodules
23. Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer
24. Serum Brain-derived Neurotrophic Factor and Antidepressant-naive Major Depression After Lung Cancer Diagnosis
25. Clinical Outcome of Small Cell Lung Cancer with Pericardial Effusion but without Distant Metastasis
26. Vascular Invasion Is a Strong Prognostic Factor After Complete Resection of Node-Negative Non-small Cell Lung Cancer
27. The antitumor activity of NK012, an SN-38–incorporating micelle, in combination with bevacizumab against lung cancer xenografts
28. Severe Interstitial Lung Disease Associated with Amrubicin Treatment
29. Hypertrophic Pulmonary Osteoarthropathy as a Paraneoplastic Manifestation of Lung Cancer
30. Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes
31. A Novel Histopathological Evaluation Method Predicting the Outcome of Non-small Cell Lung Cancer Treated by Neoadjuvant Therapy: The Prognostic Importance of the Area of Residual Tumor
32. A Phase I Study of Gemcitabine and Carboplatin in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2
33. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese
34. Performance Status and Sensitivity to First-Line Chemotherapy Are Significant Prognostic Factors in Patients With Recurrent Small Cell Lung Cancer Receiving Second-Line Chemotherapy
35. Marital status and non-small cell lung cancer survival: the Lung Cancer Database Project in Japan
36. Clinical Outcome of Chemoradiation Therapy in Patients with Limited-Disease Small Cell Lung Cancer with Ipsilateral Pleural Effusion
37. Remarkably high inhibitory effects of docosahexaenoic acid incorporated into hybrid liposomes on the growth of tumor cells along with apoptosis
38. Concurrent Chemoradiotherapy with Cisplatin and Vinorelbine for Stage III Non-small Cell Lung Cancer
39. Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population
40. Breast Cancer in First-degree Relatives and Risk of Lung Cancer: Assessment of the Existence of Gene–Sex Interactions
41. Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk
42. The Lung Cancer Database Project at the National Cancer Center, Japan: Study Design, Corresponding Rate and Profiles of Cohort
43. Interstitial Shadow on Chest CT is Associated with the Onset of Interstitial Lung Disease Caused by Chemotherapeutic Drugs
44. First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study
45. Comparison of Pharmacokinetics and Pharmacodynamics of Docetaxel and Cisplatin in Elderly and Non-Elderly Patients: Why Is Toxicity Increased in Elderly Patients?
46. High Body Mass Index Correlates with Increased Risk of Venous Irritation by Vinorelbine Infusion
47. Randomized Trial of Oral Versus Intravenous Antibiotics in Low-risk Febrile Neutropenic Patients with Lung Cancer
48. Effect of Nefiracetam, a Neurotransmission Enhancer, on Primary Uroepithelial Cells of the Canine Urinary Bladder
49. Primary Peripheral Lung Carcinoma Smaller Than 1 cm in Diameter*
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.